Wells Fargo highlights Argenx as a top Q3 pick amid strong growth and upcoming catalysts in the biotech sector.
Biotech stocks are emerging as market leaders while semiconductor shares face a prolonged rebound. The Medical sector, particularly biotech, continues to show strength despite broader volatility in tech-related equities.
Wells Fargo named Argenx a top tactical pick for Q3, citing triple-digit growth and an impending catalyst. The stock is approaching a potential buy point, reflecting investor confidence in its pipeline and earnings trajectory.
Semiconductor stocks, once market darlings, have struggled to regain momentum after recent declines. Analysts suggest the sector may require more time to stabilize before resuming upward trends.